Showing results (231-240 of 271) with videos related to
Sort By:
Pageof 28
Circulation|April 3, 2020
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart FailureJulio A Chirinos, Lei Zhao, Yi Jia, et al.Journal of Cardiac Failure|October 8, 2023
The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus ConferenceMark H Drazner, Amrut V Ambardekar, Kathryn Berlacher, et al.Cell Stem Cell|February 2, 2021
Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genesParisha P Shah, Wenjian Lv, Joshua H Rhoades, et al.Nature|November 15, 2019
Author Correction: Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.Hypertension (Dallas, Tex. : 1979)|May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.Research Square|December 4, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.Circulation Research|June 13, 2020
Epigenomes of Human Hearts Reveal New Genetic Variants Relevant for Cardiac Disease and PhenotypeWilson Lek Wen Tan, Chukwuemeka George Anene-Nzelu, Eleanor Wong, et al.Nature Cardiovascular Research|June 5, 2025
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Michelle Youlton, et al.Pageof 28